World Investment Advisors LLC Acquires New Position in National Health Investors, Inc. (NYSE:NHI)

World Investment Advisors LLC bought a new position in National Health Investors, Inc. (NYSE:NHI) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 14,795 shares of the real estate investment trust’s stock, valued at approximately $1,244,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Strategic Financial Concepts LLC acquired a new stake in National Health Investors during the second quarter worth about $28,000. Thrivent Financial for Lutherans acquired a new position in National Health Investors in the third quarter valued at $2,426,000. Acadian Asset Management LLC acquired a new stake in shares of National Health Investors during the second quarter worth $457,000. LSV Asset Management increased its stake in shares of National Health Investors by 3.7% during the second quarter. LSV Asset Management now owns 131,400 shares of the real estate investment trust’s stock worth $8,900,000 after acquiring an additional 4,700 shares during the period. Finally, ClariVest Asset Management LLC acquired a new stake in shares of National Health Investors in the 2nd quarter valued at approximately $2,465,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Performance

NHI stock opened at $72.76 on Monday. The stock’s fifty day moving average is $77.01 and its two-hundred day moving average is $75.53. The stock has a market capitalization of $3.30 billion, a price-to-earnings ratio of 25.00, a PEG ratio of 4.87 and a beta of 1.04. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. National Health Investors, Inc. has a 1 year low of $51.59 and a 1 year high of $86.13.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The firm had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business’s revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period in the previous year, the business posted $1.08 earnings per share. On average, research analysts predict that National Health Investors, Inc. will post 4.42 EPS for the current year.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be paid a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.95%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio is currently 123.71%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. StockNews.com cut National Health Investors from a “buy” rating to a “hold” rating in a report on Tuesday, October 15th. Truist Financial boosted their target price on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, August 30th. Wells Fargo & Company lowered National Health Investors from an “overweight” rating to an “equal weight” rating and increased their target price for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Finally, Bank of America started coverage on National Health Investors in a research note on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, National Health Investors has a consensus rating of “Moderate Buy” and a consensus target price of $76.33.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.